Related Experiment Video
Updated: Mar 28, 2026
03:22
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
1.3K
Prescription Strategies in Acute Uncomplicated Respiratory Infections: A Randomized Clinical Trial
Mariam de la Poza Abad1, Gemma Mas Dalmau2, Mikel Moreno Bakedano3
1Doctor Carles Ribas Primary Care Center, Barcelona, Spain.
JAMA Internal Medicine
|January 1, 2016
Summary
Delayed antibiotic prescribing for respiratory infections reduced antibiotic use without significantly worsening symptom duration or severity. Both patient-led and collection-based delayed strategies proved effective in managing symptoms while curbing unnecessary antibiotic prescriptions.
Area of Science:
- General Practice and Primary Care
- Infectious Diseases
- Pharmacology
Background:
- Delayed antibiotic prescribing is a strategy to reduce antibiotic consumption in acute respiratory infections.
- Various delayed prescription strategies exist, but their comparative effectiveness is not well-established.
- This study aimed to compare different delayed antibiotic prescribing approaches.
Purpose of the Study:
- To evaluate the efficacy and safety of two distinct delayed antibiotic prescription strategies.
- To compare these delayed strategies against immediate prescription and no antibiotic strategies.
- To assess outcomes in patients with acute, uncomplicated respiratory infections.
Main Methods:
- A pragmatic, open-label, randomized clinical trial involving 405 adults with acute respiratory infections.
- Participants were assigned to one of four groups: delayed patient-led prescription, delayed prescription collection, immediate prescription, or no antibiotic.
- Primary outcomes included symptom duration and severity, with secondary outcomes focusing on antibiotic use, patient satisfaction, and beliefs about antibiotics.
Main Results:
- Delayed strategies (patient-led and collection) resulted in substantially reduced antibiotic use compared to immediate prescription.
- Symptom burden and duration were clinically similar across all four groups, including the no antibiotic strategy.
- Patient satisfaction levels were comparable among the immediate prescription, delayed prescription, and no antibiotic groups.
Conclusions:
- Delayed antibiotic prescribing strategies are effective in reducing antibiotic use for uncomplicated respiratory infections.
- These strategies offer comparable symptom control to immediate prescribing, with no significant increase in symptom burden or duration.
- The findings support the implementation of delayed antibiotic prescribing to combat antibiotic resistance while ensuring adequate patient care.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
15.4K
06:32Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
2.6K
Related Concept Videos
01:29Acute Respiratory Failure-V
630
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
630
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
01:28Pneumonia IV: Management
1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
01:16Drugs Used in Upper Respiratory Disorders: Overview
996
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
996
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
1.6K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
1.6K
01:23Inhaled Medications
987
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
987